Continuum of Care in Pain Management: Bridging the Gap (Part 3 of 4) Case 3: Use of Opioid Medications to Manage Chronic Back Pain
neuroscienceCME Medical Simulation
Premiere Date: Monday, October 17, 2011This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Wednesday, October 17, 2012
Note: Credit Is No Longer Available
 | Steven P. Stanos, DO Executive Medical Director, Rehabilitation and Performance Medicine Swedish Pain Services Swedish Health System Seattle, WA |
In a nationwide survey, 75% of individuals with recent moderate to severe pain had seen a doctor for their pain, yet less than half of those (44%) had received adequate pain control. No uniform perspective or knowledge set exists among providers upon which to base diagnosis and management of chronic pain. Although guidelines exist and numerous pharmacological agents are available for pain management, a large gap exists regarding incorporating evidence- and outcomes-based practice, often resulting in delayed services for pain management and compromised outcomes. Physicians and their medical teams play an important role in educating their patients, families, and caregivers on optimal strategies for safely managing chronic pain.
This neuroscienceCME Medical Simulation challenges clinicians to appropriately assess chronic back pain, develop a multimodal treatment plan and also integrate education in a patient-centric model of care for chronic low back pain.
- Blyth FM, March LM, Cousins MJ. Chronic pain-related disability and use of analgesia and health services in a Sydney community. MJA. 2003;179:84-87.
- Senturk M, Ozcan PE, Talu GK, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 2002;94:11-15.
Address gaps in the diagnosis and medical management of chronic low back pain and assess patients for possible mood disorders or sleep disturbances.
At the end of this CE activity, participants should be able to:
- Identify co-morbid mood disorders and sleep disturbances in patients with chronic low back pain.
- Implement the routine use of evidence- and outcomes-based assessment tools to accurately evaluate chronic pain conditions, including low back pain.
- Communicate evolving, multimodal treatment plans to patients with chronic low back pain, while establishing realistic goals, and managing expectations in the setting of patient reported outcomes.
Supported in part by an educational grant from Endo Pharmaceuticals.
This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Supported in part by Purdue Pharma L.P.
Physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other nonphysician healthcare professionals interested in chronic low back pain.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hours
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-11-017-H01-P (recorded programs)
Activity Type: application-based
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure of Relevant Financial Relationships with Commercial Interests
CME Outfitters, LLC, adheres to the ACCME Standards, as well as those of the ACPE, APA, and ANCC, regarding commercial support of continuing medical education. It is the policy of CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Dr. Stanos has disclosed that he receives grants from Pfizer Inc. He serves as a consultant to, or is on the advisory boards of, Covidien; Eli Lilly and Company; Endo Pharmaceuticals; Grûnenthal; King Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; and Purdue Pharma L.P. He is on the speakers bureaus of Eli Lilly and Company; Endo Pharmaceuticals; Forest Laboratories, Inc.; King Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; and Pfizer Inc.
Disclosures were obtained from the planning committee members and are on file with CME Outfitters Health Office of Continuing Professional Development (OCPD) for review.
Ruth Cody, BSN, RN-BC (Content/Peer Reviewer) has no disclosures to report.
Howard Bliwise, MD (Content/Peer Reviewer) has no disclosures to report.
Nancy Jennings, MSN, MBA, MHA, RNC (Content/Peer Reviewer) has no disclosures to report.
Sharon Tordoff, CCMEP (Planning Committee) has no disclosures to report.
Joy Bartnett Leffler, MLA, NASW, CSE (Planning Committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, Endo Pharmaceuticals, Lilly USA, LLC, and Purdue Pharma L.P. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
PL-027-101711-90
